(Q35200877)

7 August 2017

1 reference

title

Management of nephrotic syndrome in children (English)

1 reference

7 August 2017

1 reference

Renee F Robinson

1

1 reference

7 August 2017

Milap C Nahata

series ordinal

2

1 reference

7 August 2017

John D Mahan

series ordinal

3

1 reference

7 August 2017

Donald L Batisky

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

23

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

1021-1036

1 reference

Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Steroid responsive nephrotic syndrome is more common in Asians

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Femoral arterial thrombosis in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Intraglomerular fibrin, platelet aggregation, and subendothelial deposits in lipoid nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Treatment of anemia of nephrotic syndrome with recombinant erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

A study of the mechanisms of edema formation in patients with the nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

The long-term course of cyclosporine-associated chronic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Low dose prednisolone in nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Long-term assessment of steroid therapy in childhood nephrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Corticosteroid therapy in nephrotic syndrome: a meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Chlorambucil treatment of frequently relapsing nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Minimal change nephrotic syndrome and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Methylprednisolone treatment of patients with steroid-resistant nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Haemorrhagic cystitis complicating cyclophosphamide treatment in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Practical aspects in the use of cyclosporin in paediatric nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Steroid-resistant, cyclosporine-responsive, relapsing nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

Does albumin and furosemide therapy affect plasma volume in nephrotic children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.8.1021.32885

10.1592/PHCO.23.8.1021.32885

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference